Notch regulates cytolytic effector function in CD8+ T cells

Journal of Immunology

Volumn 182, Issue 6, 2009, Pages 3380-3389

  Cho, Ok Hyun ^a   Shin, Hyun Mu ^a   Miele, Lucio ^b   Golde, Todd E ^c   Fauq, Abdul ^c   Minter, Lisa M ^a   Osborne, Barbara A ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; EOMESODERMIN; GRANZYME B; NOTCH RECEPTOR; NOTCH1 RECEPTOR; PERFORIN; EOMES PROTEIN, MOUSE; GRANZYME; NOTCH1 PROTEIN, MOUSE; SECRETASE; T BOX TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; BIOCHEMISTRY; CD8+ T LYMPHOCYTE; CELL ACTIVITY; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; GENETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; CYTOLOGY; CYTOTOXICITY; DRUG ANTAGONISM; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; TRANSGENIC MOUSE;

AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CYTOTOXICITY, IMMUNOLOGIC; GRANZYMES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PERFORIN; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RECEPTOR, NOTCH1; SIGNAL TRANSDUCTION; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 65449183749     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0802598     Document Type: Article

References (40)

1. Kaech, S. M., E. J. Wherry, and R. Ahmed. 2002. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2: 251-262.
2. Catalfamo, M., and P. A. Henkart. 2003. Perforin and the granule exocytosis cytotoxicity pathway. Curr. Opin. Immunol. 15: 522-527.
3. Nagata, S., and T. Suda. 1995. Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16: 39-43.
4. + T cell function by the transcription factor Eomesodermin. Science 302: 1041-1043.
5. Russ, A. P., S. Wattler, W. H. Colledge, S. A. Aparicio, M. B. Carlton, J. J. Pearce, S. C. Barton, M. A. Surani, K. Ryan, M. C. Nehls, et al. 2000. Eomesodermin is required for mouse trophoblast development and mesoderm formation. Nature 404: 95-99.
6. Palaga, T., L. Miele, T. E. Golde, and B. A. Osborne. 2003. TCR-mediated Notch signaling regulates proliferation and IFN-γ production in peripheral T cells. J. Immunol. 171: 3019-3024.
7. Bray, S. J. 2006. Notch signalling: a simple pathway becomes complex. Nat. Rev. Mol. Cell Biol. 7: 678-689.
8. Osborne, B. A., and L. M. Minter. 2007. Notch signalling during peripheral T-cell activation and differentiation. Nat. Rev. Immunol. 7: 64-75.
9. De Strooper, B., W. Annaert, P. Cupers, P. Saftig, K. Craessaerts, J. S. Mumm, E. H. Schroeter, V. Schrijvers, M. S. Wolfe, W. J. Ray, et al. 1999. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 398: 518-522.
10. Struhl, G., and A. Adachi. 1998. Nuclear access and action of notch in vivo. Cell 93: 649-660.
11. Kopan, R., and M. X. Ilagan. 2004. Gamma-secretase: proteasome of the membrane? Nat. Rev. Mol. Cell Biol. 5: 499-504.
12. Minter, L. M., D. M. Turley, P. Das, H. M. Shin, I. Joshi, R. G. Lawlor, O. H. Cho, T. Palaga, S. Gottipati, J. C. Telfer, et al. 2005. Inhibitors of gammasecretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21. Nat. Immunol. 6: 680-688.
13. + T cells. J. Exp. Med. 204: 2015-2021.
14. + T cell fate coupled by T-bet and eomesodermin. Nat. Immunol. 6: 1236-1244.
15. Cheng, P., A. Zlobin, V. Volgina, S. Gottipati, B. Osborne, E. J. Simel, L. Miele, and D. I. Gabrilovich. 2001. Notch-1 regulates NF-κB activity in hemopoietic progenitor cells. J. Immunol. 167: 4458-4467.
16. Adler, S. H., E. Chiffoleau, L. Xu, N. M. Dalton, J. M. Burg, A. D. Wells, M. S. Wolfe, L. A. Turka, and W. S. Pear. 2003. Notch signaling augments T cell responsiveness by enhancing CD25 expression. J. Immunol. 171: 2896-2903.
17. Shin, H. M., L. M. Minter, O. H. Cho, S. Gottipati, A. H. Fauq, T. E. Golde, G. E. Sonenshein, and B. A. Osborne. 2006. Notch1 augments NF-κB activity by facilitating its nuclear retention. EMBO J. 25: 129-138.
18. Wang, C. D., G. D. Chang, Y. K. Lee, and H. Chen. 2001. A functional composite cis-element for NFκb and RBJκ in the rat pregnancy-specific glycoprotein gene. Biol. Reprod. 65: 1437-1443.
19. Beverly, L. J., and A. J. Capobianco. 2004. Targeting promiscuous signaling pathways in cancer: another Notch in the bedpost. Trends Mol. Med. 10: 591-598.
20. Shirakata, Y., J. D. Shuman, and J. E. Coligan. 1996. Purification of a novel MHC class I element binding activity from thymus nuclear extracts reveals that thymic RBP-Jκ/CBF1 binds to NF-κB-like elements. J. Immunol. 156: 4672-4679.
21. Moore, M. W., F. R. Carbone, and M. J. Bevan. 1988. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54: 777-785.
22. Nair, S., P. A. Wearsch, D. A. Mitchell, J. J. Wassenberg, E. Gilboa, and C. V. Nicchitta. 1999. Calreticulin displays in vivo peptide-binding activity and can elicit CTL responses against bound peptides. J. Immunol. 162: 6426-6432.
23. Nair, S. K., D. Snyder, B. T. Rouse, and E. Gilboa. 1997. Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts. Int. J. Cancer 70: 706-715.
24. Glimcher, L. H., M. J. Townsend, B. M. Sullivan, and G. M. Lord. 2004. Recent developments in the transcriptional regulation of cytolytic effector cells. Nat. Rev. Immunol. 4: 900-911.
25. Kagi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265: 528-530.
26. Nakazawa, T., K. Agematsu, and A. Yabuhara. 1997. Later development of Fas ligand-mediated cytotoxicity as compared with granule-mediated cytotoxicity during the maturation of natural killer cells. Immunology 92: 180-187.
27. Aoyama, K., C. Delaney, B. Varnum-Finney, A. D. Kohn, R. T. Moon, and I. D. Bernstein. 2007. The interaction of the Wnt and Notch pathways modulates Nk vs. T cell differentiation. Stem Cells 25: 2488-2497.
28. De Smedt, M., T. Taghon, I. Van de Walle, G. De Smet, G. Leclercq, and J. Plum. 2007. Notch signaling induces cytoplasmatic CD3ε expression in human differentiating NK cells. Blood 110: 2696-2703.
29. DeHart, S. L., M. J. Heikens, and S. Tsai. 2005. Jagged2 promotes the development of natural killer cells and the establishment of functional natural killer cell lines. Blood 105: 3521-3527.
30. Lehar, S. M., J. Dooley, A. G. Farr, and M. J. Bevan. 2005. Notch ligands Delta 1 and Jagged1 transmit distinct signals to T-cell precursors. Blood 105: 1440-1447.
31. Rolink, A. G., G. Balciunaite, C. Demoliere, and R. Ceredig. 2006. The potential involvement of Notch signaling in NK cell development. Immunol. Lett. 107: 50-57.
32. Robey, E., and B. J. Fowlkes. 1994. Selective events in T cell development. Annu. Rev. Immunol. 12: 675-705.
33. Wolfer, A., T. Bakker, A. Wilson, M. Nicolas, V. Ioannidis, D. R. Littman, P. P. Lee, C. B. Wilson, W. Held, H. R. MacDonald, and F. Radtke. 2001. Inactivation of Notch 1 in immature thymocytes does not perturb CD4 or CD8 T cell development. Nat. Immunol. 2: 235-241.
34. + T-cell lineage fate. Nature 404: 506-510.
35. Doerfler, P., M. S. Shearman, and R. M. Perlmutter. 2001. Presenilin-dependent gamma-secretase activity modulates thymocyte development. Proc. Natl. Acad. Sci. USA 98: 9312-9317.
36. Pear, W. S., and F. Radtke. 2003. Notch signaling in lymphopoiesis. Semin. Immunol. 15: 69-79.
37. Robey, E., and M. Schlissel. 2003. Lymphocyte development. Curr. Opin. Immunol. 15: 155-157.
38. + T-cell response. Nat. Rev. Immunol. 4: 595-602.
39. Maekawa, Y., Y. Minato, C. Ishifune, T. Kurihara, A. Kitamura, H. Kojima, H. Yagita, M. Sakata-Yanagimoto, T. Saito, I. Taniuchi, et al. 2008. Notch2 integrates signaling by the transcription factors RBP-J and CREB1 to promote T cell cytotoxicity. Nat. Immunol. 9: 1140-1147.
40. Mayer, K. D., K. Mohrs, W. Reiley, S. Wittmer, J. E. Kohlmeier, J. E. Pearl, A. M. Cooper, L. L. Johnson, D. L. Woodland, and M. Mohrs. 2008. Cutting edge: T-bet and IL-27R are critical for in vivo IFN-γ production by CD8 T cells during infection. J. Immunol. 180: 693-697.